.jpg?versionId=609)
AAI and its journals, The Journal of Immunology and ImmunoHorizons, have become aware that a predatory publisher is sending emails to authors to solicit manuscript submissions. To better inform our valued authors, we compiled a resource on how to spot a predatory publisher.Learn more by visiting this FAQ
Did you know that manuscripts posted to the bioRxiv preprint server can be transferred directly to The Journal of Immunology for peer review? No need to re-upload files or re-enter information at the submission site! For more information, visit information for authors.
The Journal of Immunology
The Journal of Immunology (The JI) publishes peer-reviewed manuscripts describing novel findings in all areas of experimental immunology, including both basic and clinical studies.
Impact Factor 5.426
COVID-19, SARS, and MERS Articles
Coronavirus Disease 2019 (COVID-19), Severe Acute Respiratory Syndrome (SARS), and Middle Eastern Respiratory Syndrome (MERS) articles in AAI journals. All articles are free to access.
ImmunoHorizons
ImmunoHorizons is a fully open access, peer-reviewed, online-only journal committed to advancing the knowledge of immunology. All editorial decisions are made by practicing scientists.
AAI Newsletter
The October 2022 issue of the AAI Newsletter is available now online!
Sign Up for New Issue Alerts
Wondering when the next issues of The JI or ImmunoHorizons are coming out?
Sign up for email alerts so that you don't miss an single issue!
